These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6804088)

  • 21. [Studies on the prevention of side-effects of the anti-cancer agent, mitomycin C by xylitol].
    Iwasa H; Takahashi M
    Gan No Rinsho; 1968 Jul; 14(7):561-5. PubMed ID: 5749780
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):675-84. PubMed ID: 5753587
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
    Chang BK; Gutman R
    Cancer Res; 1982 Jul; 42(7):2666-70. PubMed ID: 6805945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angina pectoris after doxorubicin and mitomycin therapy.
    Ganz PA; Gold BS; Tandron I; Lurie K
    Cancer Treat Rep; 1983 Jan; 67(1):98-9. PubMed ID: 6616501
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
    Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].
    Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Asanuma F; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):638-45. PubMed ID: 6820902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intratumoral injection therapy of mitomycin C adsorbed to activated carbon particles under ultrasound guidance for pancreatic cancer].
    Moriai T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec; 82(12):2994. PubMed ID: 3938492
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biliary and pancreatic excretion of mitomycin C, with special reference to the concomitant use of urokinase].
    Suda Y; Sekine T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2225-6. PubMed ID: 3933436
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on preoperative cancer chemotherapy. Effects of preoperative intra-arterial infusion of methotrexate and mitomycin C on stomach cancer.
    Fujimoto S; Urushibara O; Watanabe Y; Miyoshi T; Adachi M
    Jpn J Surg; 1971 Mar; 1(1):72-82. PubMed ID: 4950886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study on the combined therapy of surgery and mitomycin C administration for stomach cancer].
    Ishikawa Y; Kakuta H; Komaba M; Sato K; Yagihashi H
    Geka Chiryo; 1969 May; 20(5):488-95. PubMed ID: 5820209
    [No Abstract]   [Full Text] [Related]  

  • 33. [Indication and effect of intra-arterial injection of mitomycin microcapsules in the treatment of kidney cancer].
    Kato T; Shindo M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):357-64. PubMed ID: 6820895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
    Cocconi G; DeLisi V; Di Blasio B
    Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy with 5-FU 1-(aminomethyl)-3-(2-chloroethyl)-3-nitrosourea (ACNU), and mitomycin (FUM) for carcinoma of the pancreas.
    Meguro S; Kuraishi Y; Ichiba K; Abe M; Yoda T; Mikouchi S
    Cancer Treat Rep; 1982 Aug; 66(8):1645-6. PubMed ID: 6955023
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
    Fennelly D; Kelsen DP
    Hepatogastroenterology; 1996; 43(8):356-62. PubMed ID: 8714228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
    Biran H; Sulkes A; Biran S
    Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
    [No Abstract]   [Full Text] [Related]  

  • 38. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; MacDonald JS; Hoth D; Woolley PV
    Recent Results Cancer Res; 1978; 63():148-51. PubMed ID: 705009
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of pancreatic cancer surviving for 7 years 11 months following intra-arterial and portal infusion chemotherapy].
    Kenmotsu M; Endo T; Ishii H; Ichikawa J; Tsunemitsu K
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1983-5. PubMed ID: 7487131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
    Trux F
    Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.